Disclaimer: This article provides general information and is not a substitute for medical advice
Potential clinical consequences include: Development of anti-drug antibodies (ADAs) Reduced therapeutic efficacy Altered pharmacokinetics Injection-site reactions or systemic hypersensitivity Regulators therefore place strong emphasis on impurity profiles that could increase immunogenic potential beyond that of the Reference Listed Drug (RLD) Impurity Attributes That Increase Immunogenic Risk Not all impurities pose equal immunogenic concern
The effect of glutamine supplementation on serum levels of some inflammatory factors, oxidative stress, and appetite in COVID-19 patients: a casecontrol study
Moreover, it should be highlighted that SEMA-RM-LNC had a better trend than SEMA ORAL, RYBELSUS SUSP and RM-LNC and better than our exenatide-loaded lipid nanocapsules (EXE-RM-LNC), which were used in our previous studies [10]
Pharmaceutical Development: Researchers use it to enhance drug efficacy and stability, particularly in formulations aimed at improving patient outcomes in chronic diseases
Besides, few lines of evidence have been provided regarding the differentiation of the roles of exercise in atherosclerosis based on age and race
